tiprankstipranks
Star Combo Pharma Ltd. (AU:S66)
ASX:S66
Australian Market
Holding AU:S66?
Track your performance easily

Star Combo Pharma Ltd. (S66) Financial Statements

1 Followers

Star Combo Pharma Ltd. Financial Overview

Star Combo Pharma Ltd.'s market cap is currently ―. The company's EPS TTM is AU$0.005; its P/E ratio is 21.82; and it has a dividend yield of 3.08%. Star Combo Pharma Ltd. is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19
Income Statement-
Total Revenue----
Gross Profit----
EBIT----
EBITDA----
Net Income Common Stockholders----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 10.39MAU$ 17.32MAU$ 26.60MAU$ 4.62M
Total AssetsAU$ 43.44MAU$ 43.32MAU$ 54.72MAU$ 27.51M
Total DebtAU$ 4.12MAU$ 3.30MAU$ 5.61MAU$ 47.74K
Net DebtAU$ -6.27MAU$ -14.03MAU$ -20.99MAU$ -4.57M
Total LiabilitiesAU$ 8.04MAU$ 7.13MAU$ 10.22MAU$ 7.51M
Stockholders EquityAU$ 35.41MAU$ 36.19MAU$ 44.50MAU$ 20.00M
Cash Flow-
Free Cash Flow----
Operating Cash Flow----
Investing Cash Flow----
Financing Cash Flow----
Currency in AUD

Star Combo Pharma Ltd. Earnings and Revenue History

Star Combo Pharma Ltd. Debt to Assets

Star Combo Pharma Ltd. Cash Flow

Star Combo Pharma Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis